Zepatier Is FDA-Approved to Treat Hepatitis C | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Painful Liver Biopsies May Be a Thing of the Past

Back to News Homepage
Next

Beyond the Liver: Milk Thistle’s 4 Extra Benefits

Zepatier Is FDA-Approved to Treat Hepatitis C

The Editors at Hepatitis Central
January 29, 2016

Print this page

Less costly than previously approved treatments, learn more about Merck’s newly FDA-approved Zepatier for Hepatitis C patients.
Pin it on Pinterest

FDA OKs Merck’s Zepatier (Grazoprevir/Elbasvir) to Treat Hep C

The U.S. Food and Drug Administration (FDA) has approved Merck’s once-daily fixed-dose combination tablet Zepatier (grazoprevir/elbasvir), with or without ribavirin, to treat those with genotypes 1 and 4 hepatitis C virus (HCV).

Zepatier (ZEP’-ah-teer”) includes NS3/4A protease inhibitor grazoprevir and the NS5A replication complex inhibitor elbasvir.

Continue reading this entire article:
https://www.hepmag.com/article/fda-oks-mercks-zepatier-grazoprevirelbasvir-treat-hepatitis-c

2 Comments
Share
Share
Previous

Painful Liver Biopsies May Be a Thing of the Past

Back to News Homepage
Next

Beyond the Liver: Milk Thistle’s 4 Extra Benefits

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.

2 Comments

  • trotter says:

    Thank you, Merck for paying attention to us Hepatitis C sufferers. And thank you for giving a message to Gilead by making your tx 1/2 the price of existing companies. Your company has manufactured medicines for Hep C for 25 years. I have a feeling that you are motivated not simply for money. If so. we appreciate it.

  • SuziQ says:

    I’m 81 and completed my Merck clinical trial 2 years ago and remain SVR. Easy trial–even with ribavirin. That was the arm of the trial I got. So glad it is finally available for geno 1 and 3 or 4. can’t remember which. Gilead refused me for their trials because I had cirrhosis.

Leave a Reply

Your email address will not be published. Required fields are marked *